This included the “objective measures” reflecting inflammation (SJC,CRP), whereas ACPA-negative RA patients with obesity did not have more inflammation as assessed by SJC and CRP during the disease course compared to normal weight patients. The gene discussed is PRTN3; the disease is obesity due to melanocortin 4 receptor deficiency.